A5361s is a prospective study to determine the effects of pitavastatin on physical function. The study will enroll participants...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
The investigators are looking for a better way to prevent cervical cancer. This study is comparing two different methods to...
